Childhood Acute Lymphoblastic Leukemia Survival in patient treated with ALL-IC-BFM 2009 protocol and social support in Bogota-Colombia
Article Sidebar
Main Article Content
Abstract
Introduction: Acute Lymphoid Leukemia is the most frequent neoplasm in childhood, and therefore, the treatment strategy and access to each of the interventions are defining aspects in the patient's cure. Objectives: To determine the overall and event-free survival of patients with Acute Lymphoid Leukemia treated with a strategy based on the Intercontinental Berlin Frankfurt and Münster Acute Lymphoid Leukemia protocol (ALL-IC-BFM 2009) with a permanent administrative follow-up program to which they are admitted. The patient once the oncological diagnosis is made. To establish the patients' survival according to the assigned risk group and describe the relapse rate in the evaluated group. Methods: 51 patients under 18 years of age diagnosed with Acute Lymphoid Leukemia, treated with the ALL-IC-BFM 2009 strategy, entered the comprehensive care program for cancer patients at the Colsubsidio Children's Clinic, were followed for four years. Observational prospective cohort study with survival analysis. Results: Overall survival for the 4-year cohort was 71.1%, while event-free survival was 69.4%. According to the risk groups, the overall survival was 89%; for the standard risk, it was 85.2% for the intermediate-risk group and 39.8% for the high-risk group. Conclusions: Overall survival behaved as reported in the region; however, the results obtained in standard and intermediate-risk patients exceeded overall survival.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Creative Commons
License Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
You are free to:
Share - copy and redistribute the material in any medium or format.
Adapt - remix, transform, and build upon the material The licensor cannot revoke these freedoms as long as you follow the license terms.
• Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
• NonCommercial — You may not use the material for commercial purposes.
• ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
• No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
References
Foucher - E, Stiller C, Lacour B, Kaatsch. Age-Adjusted and Age-Specific SEER Cancer Incidence Rates, 2010-2014a By International Classification of Childhood Cancer (ICCC). Cancer. 2005;103(7):1457–67. Disponible en: https://seer.cancer.gov/csr/1975_2014/results_single/sect_29_table.01_2pgs.pdf
Stary J, Zimmermann M, Campbell M, Castillo L, Dibar E, Donska S, et al. Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 2002. J Clin Oncol. 2014;32(3):174–84. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24344215
Möricke A, Zimmermann M, Reiter A, Henze G, Schrauder A, Gadner H, et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia. 2010;24(2):265–84. Disponible en: http://www.nature.com/articles/leu2009257
Eduardo L, García LS, Collazos P, Ramirez O. Descriptive epidemiology of childhood cancer in Cali, Colombia 1977-2011. Colombia Médica. 2013;155-164 p. Disponible en: http://colombiamedica.univalle.edu.co/index.php/comedica/article/view/1243/2144
Suárez A, Piña M, Nichols-Vinueza DX, Lopera J, Rengifo L, Mesa M, et al. A strategy to improve treatment-related mortality and abandonment of therapy for childhood ALL in a developing country reveals the impact of treatment delays. Pediatr Blood Cancer. 2015;62(8):1395–402. Disponible en: http://doi.wiley.com/10.1002/pbc.25510
Gupta S, Bonilla M, Fuentes SL, Caniza M, Howard SC, Barr R, et al. Incidence and predictors of treatment-related mortality in paediatric acute leukaemia in El Salvador. Br J Cancer. 2009;100(7):1026–31. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/19293804
Vizcaíno M, Lopera JE, Martínez L, Reyes ID los, Linares A. Guía de atención integral para la detección oportuna, diagnóstico, tratamiento y seguimiento de leucemia linfoide aguda en niños, niñas y adolescentes. Rev Colomb Cancerol. 2016;20(1):17–27. Disponible en: http://linkinghub.elsevier.com/retrieve/pii/S0123901515000918
Ruiz J Á, Gómez - Restrepo C. Epidemiología clínica - Investigación clínica aplicada. Segunda ed. Bogotá; 2015. 299-324 p.
Rebasa P. Conceptos básicos del análisis de supervivencia. Cirugía Española. 2005;78(4):222–30. Disponible en: http://linkinghub.elsevier.com/retrieve/pii/S0009739X05709234
Kamps WA, van der Pal-de Bruin KM, Veerman AJP, Fiocco M, Bierings M, Pieters R. Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004. Leukemia. 2010;24(2):309–19. Disponible en: http://www.nature.com/articles/leu2009258
Pui C-H, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360(26):2730–41. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/19553647
Schrappe M, Hunger SP, Pui C-H, Saha V, Gaynon PS, Baruchel A, et al. Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia. N Engl J Med. 2012;366(15):1371–81. Disponible en: http://www.nejm.org/doi/abs/10.1056/NEJMoa1110169
Campbell M, Castillo L, Cecilia Riccheri D, Janez Jazbec A, Kaiserova E, Konja J, et al. A Randomized Trial of the I-BFM-SG for the Management of Childhood non-B Acute Lymphoblastic Leukemia ALL IC-BFM 2009 – TRIAL STEERING COMMITTEE. 2009. Disponible en: http://www.tphd.org.tr/wp-content/uploads/2017/11/Lebriz_Yuksel_ALLIC_BFM_2009.pdf